Rebbaa A et al. |
Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent. |
2008 |
Angiogenesis |
pmid:18386142
|
Wu X et al. |
Trichostatin A improved epigenetic modifications of transfected cells but did not improve subsequent cloned embryo development. |
2008 |
Anim. Biotechnol. |
pmid:18855246
|
BurlibaÅŸa L and Zarnescu O |
In vivo effects of Trichostatin A - A histone deacetylase inhibitor - On chromatin remodeling during Triturus cristatus spermatogenesis. |
2013 |
Anim. Reprod. Sci. |
pmid:24100069
|
Wittayarat M et al. |
Epigenetic modulation on cat-cow interspecies somatic cell nuclear transfer embryos by treatment with trichostatin A. |
2017 |
Anim. Sci. J. |
pmid:27506538
|
Cong P et al. |
Effects of trichostatin A on histone acetylation and methylation characteristics in early porcine embryos after somatic cell nuclear transfer. |
2013 |
Anim. Sci. J. |
pmid:23607426
|
Himaki T et al. |
Effects of trichostatin A on in vitro development and transgene function in somatic cell nuclear transfer embryos derived from transgenic Clawn miniature pig cells. |
2010 |
Anim. Sci. J. |
pmid:20887307
|
Boutillier AL et al. |
Constitutive repression of E2F1 transcriptional activity through HDAC proteins is essential for neuronal survival. |
2002 |
Ann. N. Y. Acad. Sci. |
pmid:12485907
|
Tian F et al. |
Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons. |
2010 |
Ann. N. Y. Acad. Sci. |
pmid:20633124
|
Parekh-Olmedo H et al. |
The effect of hydroxyurea and trichostatin a on targeted nucleotide exchange in yeast and Mammalian cells. |
2003 |
Ann. N. Y. Acad. Sci. |
pmid:14751821
|
Williams PJ et al. |
HDAC inhibitor trichostatin A suppresses osteoclastogenesis by upregulating the expression of C/EBP-β and MKP-1. |
2011 |
Ann. N. Y. Acad. Sci. |
pmid:22172035
|
Sourlingas TG et al. |
Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age. |
2007 |
Ann. N. Y. Acad. Sci. |
pmid:18056955
|
Yoshida M and Horinouchi S |
Trichostatin and leptomycin. Inhibition of histone deacetylation and signal-dependent nuclear export. |
1999 |
Ann. N. Y. Acad. Sci. |
pmid:10667200
|
Marsili G et al. |
Role of acetylases and deacetylase inhibitors in IRF-1-mediated HIV-1 long terminal repeat transcription. |
2004 |
Ann. N. Y. Acad. Sci. |
pmid:15659847
|
Sowa Y et al. |
Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites. |
1999 |
Ann. N. Y. Acad. Sci. |
pmid:10667218
|
Kim YB et al. |
Selective induction of cyclin-dependent kinase inhibitors and their roles in cell cycle arrest caused by trichostatin A, an inhibitor of histone deacetylase. |
1999 |
Ann. N. Y. Acad. Sci. |
pmid:10667219
|
Kraus J |
Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T lymphocytes. |
2012 |
Ann. N. Y. Acad. Sci. |
pmid:22823387
|
Yasui W et al. |
Histone acetylation and gastrointestinal carcinogenesis. |
2003 |
Ann. N. Y. Acad. Sci. |
pmid:12724227
|
Narver HL et al. |
Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition. |
2008 |
Ann. Neurol. |
pmid:18661558
|
Li RJ et al. |
Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance. |
2010 |
Ann. Oncol. |
pmid:20038517
|
Grabiec AM et al. |
Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay. |
2012 |
Ann. Rheum. Dis. |
pmid:21953341
|
Iliopoulos D et al. |
Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. |
2007 |
Ann. Rheum. Dis. |
pmid:17502362
|
Jüngel A et al. |
Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis. |
2006 |
Ann. Rheum. Dis. |
pmid:16284094
|
Liu S et al. |
Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells. |
2013 |
Ann. Surg. Oncol. |
pmid:22752337
|
Mukhopadhyay NK et al. |
Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer. |
2006 |
Ann. Thorac. Surg. |
pmid:16488717
|
Swanson S |
Invited commentary. |
2006 |
Ann. Thorac. Surg. |
pmid:16488718
|
Chen Z et al. |
Promotion of Metastasis-associated Gene Expression in Survived PANC-1 Cells Following Trichostatin A Treatment. |
2015 |
Anticancer Agents Med Chem |
pmid:25991546
|
Rahim R and Strobl JS |
Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells. |
2009 |
Anticancer Drugs |
pmid:19584707
|
Hong S et al. |
Differential regulation of thrombospondin-1 expression and antiangiogenesis of ECV304 cells by trichostatin A and helixor A. |
2007 |
Anticancer Drugs |
pmid:17704650
|
Monks A et al. |
Gene expression-signature of belinostat in cell lines is specific for histone deacetylase inhibitor treatment, with a corresponding signature in xenografts. |
2009 |
Anticancer Drugs |
pmid:19606018
|
Wittich S et al. |
Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell lines. |
2005 |
Anticancer Drugs |
pmid:15930892
|
Arany I et al. |
Epigenetic modifiers exert renal toxicity through induction of p66shc. |
2011 |
Anticancer Res. |
pmid:21965735
|
Shu ST et al. |
Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells. |
2010 |
Anticancer Res. |
pmid:20651337
|
Höring E et al. |
The histone deacetylase inhibitor trichostatin a promotes apoptosis and antitumor immunity in glioblastoma cells. |
2013 |
Anticancer Res. |
pmid:23564772
|
Dressel U et al. |
Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer. |
2000 Mar-Apr |
Anticancer Res. |
pmid:10810390
|
Kawano T et al. |
Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect. |
2004 Sep-Oct |
Anticancer Res. |
pmid:15517875
|
Noss KR et al. |
Methylation state of the prostate specific membrane antigen (PSMA) CpG island in prostate cancer cell lines. |
2002 May-Jun |
Anticancer Res. |
pmid:12168830
|
Yasuda K et al. |
ERas oncogene expression and epigenetic regulation by histone acetylation in human cancer cells. |
2007 Nov-Dec |
Anticancer Res. |
pmid:18225573
|
Kuwajima A et al. |
The histone deacetylase inhibitor butyrate inhibits melanoma cell invasion of Matrigel. |
2007 Nov-Dec |
Anticancer Res. |
pmid:18225587
|
Jasek E et al. |
Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells. |
2012 |
Anticancer Res. |
pmid:22753739
|
Nadasi E et al. |
Epigenetic modifiers exacerbate oxidative stress in renal proximal tubule cells. |
2009 |
Anticancer Res. |
pmid:19528494
|
Jung AR et al. |
Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin--a treatment. |
2013 |
Anticancer Res. |
pmid:23482750
|
Yap OW et al. |
Epigenetic modifications of the Estrogen receptor beta gene in epithelial ovarian cancer cells. |
2009 |
Anticancer Res. |
pmid:19331143
|
Emionite L et al. |
Histone deacetylase inhibitors enhance retinoid response in human breast cancer cell lines. |
2004 Nov-Dec |
Anticancer Res. |
pmid:15736447
|
Wilson DW et al. |
Defining the timing of action of antimalarial drugs against Plasmodium falciparum. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23318799
|
Andrews KT et al. |
Potent antimalarial activity of histone deacetylase inhibitor analogues. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18212103
|
Smith WL and Edlind TD |
Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12384361
|
Varma A and Kwon-Chung KJ |
Heteroresistance of Cryptococcus gattii to fluconazole. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20385871
|
Dow GS et al. |
Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18644969
|
Luo B et al. |
A possible strategy to produce pigs resistant to porcine reproductive and respiratory syndrome virus. |
2013 |
Antiviral Res. |
pmid:23732571
|
Chiou SK and Hoa N |
Up-regulation of GADD45alpha expression by NSAIDs leads to apoptotic and necrotic colon cancer cell deaths. |
2009 |
Apoptosis |
pmid:19757064
|
Reddy RM et al. |
Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascade. |
2007 |
Apoptosis |
pmid:17136498
|
Zhang CZ et al. |
Trichostatin A sensitizes HBx-expressing liver cancer cells to etoposide treatment. |
2011 |
Apoptosis |
pmid:21468663
|
Ninios YP et al. |
Histone H1 subtype preferences of DFF40 and possible nuclear localization of DFF40/45 in normal and trichostatin A-treated NB4 leukemic cells. |
2010 |
Apoptosis |
pmid:19882353
|
Facchetti F et al. |
Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors. |
2004 |
Apoptosis |
pmid:15314285
|
Roh MS et al. |
Mechanism of histone deacetylase inhibitor Trichostatin A induced apoptosis in human osteosarcoma cells. |
2004 |
Apoptosis |
pmid:15314286
|
Chen T et al. |
Histone acetylation is involved in hsp70 gene transcription regulation in Drosophila melanogaster. |
2002 |
Arch. Biochem. Biophys. |
pmid:12464268
|
Bort R et al. |
Role of hepatocyte nuclear factor 3 gamma in the expression of human CYP2C genes. |
2004 |
Arch. Biochem. Biophys. |
pmid:15130783
|
Adachi T et al. |
Histone deacetylase inhibitors stimulate the susceptibility of A549Â cells to a plasma-activated medium treatment. |
2016 |
Arch. Biochem. Biophys. |
pmid:27470189
|
Katula KS et al. |
Cell cycle specific changes in the human cyclin B1 gene regulatory region as revealed by response to trichostatin A. |
2002 |
Arch. Biochem. Biophys. |
pmid:12054478
|
Garrison PM et al. |
Effects of histone deacetylase inhibitors on the Ah receptor gene promoter. |
2000 |
Arch. Biochem. Biophys. |
pmid:10666294
|
Wood M et al. |
Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6. |
2018 |
Arch. Biochem. Biophys. |
pmid:29233643
|
Sichtig N et al. |
Papillomavirus binding factor binds to SAP30 and represses transcription via recruitment of the HDAC1 co-repressor complex. |
2007 |
Arch. Biochem. Biophys. |
pmid:17897615
|
Senawong T et al. |
BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. |
2005 |
Arch. Biochem. Biophys. |
pmid:15639232
|
Diao JS et al. |
Trichostatin A inhibits collagen synthesis and induces apoptosis in keloid fibroblasts. |
2011 |
Arch. Dermatol. Res. |
pmid:21400246
|
Zhu K et al. |
Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors. |
2008 |
Arch. Gynecol. Obstet. |
pmid:17680259
|
Hizume K et al. |
Nano-scale analyses of the chromatin decompaction induced by histone acetylation. |
2010 |
Arch. Histol. Cytol. |
pmid:22572182
|
Royce SG et al. |
Effects of the histone deacetylase inhibitor, trichostatin A, in a chronic allergic airways disease model in mice. |
2012 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:22684086
|
Piotrowska H and Jagodzinski PP |
Glucocorticoid receptor alpha and beta variant expression is associated with ASF/SF2 splicing factor upregulation in HT-29 colon cancer and MCF-7 breast carcinoma cells. |
2009 |
Arch. Med. Res. |
pmid:19427965
|
Hou SY et al. |
Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism. |
2014 |
Arch. Med. Res. |
pmid:24316396
|
Yu L et al. |
Trichostatin A ameliorates myocardial ischemia/reperfusion injury through inhibition of endoplasmic reticulum stress-induced apoptosis. |
2012 |
Arch. Med. Res. |
pmid:22564421
|
Cunneen TS et al. |
In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells. |
2009 |
Arch. Ophthalmol. |
pmid:19365017
|
Schmidt K et al. |
Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells. |
1999 |
Arch. Pharm. (Weinheim) |
pmid:10575368
|
Ahn MR et al. |
Trichostatin A, a histone deacetylase inhibitor stimulate CYP3A4 proximal promoter activity in Hepa-I cells. |
2004 |
Arch. Pharm. Res. |
pmid:15180307
|
Han SB and Lee JK |
Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages. |
2009 |
Arch. Pharm. Res. |
pmid:19407980
|
Kim SN et al. |
Regulation of adipocyte differentiation by histone deacetylase inhibitors. |
2009 |
Arch. Pharm. Res. |
pmid:19407971
|
Joung KE et al. |
Antiproliferative effect of trichostatin A and HC-toxin in T47D human breast cancer cells. |
2004 |
Arch. Pharm. Res. |
pmid:15283467
|
Min KN et al. |
Estrogen receptor enhances the antiproliferative effects of trichostatin A and HC-toxin in human breast cancer cells. |
2004 |
Arch. Pharm. Res. |
pmid:15202563
|
Shinde V et al. |
Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Tox and STOP-Tox tests. |
2017 |
Arch. Toxicol. |
pmid:27188386
|
Pallocca G et al. |
Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. |
2016 |
Arch. Toxicol. |
pmid:26705709
|
Rempel E et al. |
A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. |
2015 |
Arch. Toxicol. |
pmid:26272509
|
Balmer NV et al. |
From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. |
2014 |
Arch. Toxicol. |
pmid:24935251
|
Zapletal O et al. |
Butyrate alters expression of cytochrome P450 1A1 and metabolism of benzo[a]pyrene via its histone deacetylase activity in colon epithelial cell models. |
2017 |
Arch. Toxicol. |
pmid:27830268
|
Cipriano M et al. |
The role of epigenetic modifiers in extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells. |
2017 |
Arch. Toxicol. |
pmid:27909741
|
Lu MC et al. |
Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A. |
2009 |
Arch. Toxicol. |
pmid:18709356
|
Nordén R et al. |
Inhibition of protein deacetylation augments herpes simplex virus type 1-activated transcription of host fucosyltransferase genes associated with virus-induced sLex expression. |
2010 |
Arch. Virol. |
pmid:20039087
|
Dje N'Guessan P et al. |
Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19122173
|
Choi JH et al. |
Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:16141407
|
Inoue K et al. |
Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression. |
2006 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17008592
|
Colussi C et al. |
P300/CBP associated factor regulates nitroglycerin-dependent arterial relaxation by N(ε)-lysine acetylation of contractile proteins. |
2012 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:22859492
|
Cai D et al. |
Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis. |
2015 |
Arthritis Res. Ther. |
pmid:26408027
|
Misaki K et al. |
Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice. |
2011 |
Arthritis Res. Ther. |
pmid:21592365
|
Gillespie J et al. |
Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients. |
2012 |
Arthritis Rheum. |
pmid:21952924
|
Farrajota K et al. |
Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. |
2005 |
Arthritis Rheum. |
pmid:15641079
|
Culley KL et al. |
Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation. |
2013 |
Arthritis Rheum. |
pmid:23575963
|
Wang Y et al. |
Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. |
2006 |
Arthritis Rheum. |
pmid:16802366
|
Huber LC et al. |
Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. |
2007 |
Arthritis Rheum. |
pmid:17665426
|
Hemmatazad H et al. |
Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. |
2009 |
Arthritis Rheum. |
pmid:19404935
|
Shi QQ et al. |
Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling. |
2014 |
Asian Pac. J. Cancer Prev. |
pmid:25292076
|
Zohre S et al. |
Trichostatin A-induced apoptosis is mediated by Kruppel-like factor 4 in ovarian and lung cancer. |
2014 |
Asian Pac. J. Cancer Prev. |
pmid:25169491
|
Zhang QC et al. |
Histone deacetylase inhibitor trichostatin A enhances anti-tumor effects of docetaxel or erlotinib in A549 cell line. |
2012 |
Asian Pac. J. Cancer Prev. |
pmid:22994780
|